Telomir Pharmaceuticals, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Telomir Pharmaceuticals, Inc. has issued a proxy statement detailing its upcoming Annual Meeting of Shareholders, scheduled for September 11, 2026, to elect directors, ratify auditor appointment, and address other business.